BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23963773)

  • 1. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
    Tao Y; Liang G
    Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between +61G polymorphism of the EGF gene and glioma risk in different ethnicities: a meta-analysis.
    Tan D; Xu J; Li Y; Lai R
    Tohoku J Exp Med; 2010 Dec; 222(4):229-35. PubMed ID: 21123997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis.
    Chen X; Yang G; Zhang D; Zhang W; Zou H; Zhao H; Zhang X; Zhao S
    PLoS One; 2014; 9(4):e95139. PubMed ID: 24740103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between EGF +61 G/A and glioma risk in a Chinese population.
    Wang S; Zhao Y; Ruan Z; Chen H; Fan W; Chen J; Wu Q; Qian J; Zhang T; Huang Y; Lu D
    BMC Cancer; 2010 May; 10():221. PubMed ID: 20487573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between GSTP1 Ile105Val polymorphism and glioma risk: a systematic review and meta-analysis.
    Xie P; Liang Y; Liang G; Liu B
    Tumour Biol; 2014 Jan; 35(1):493-9. PubMed ID: 23975366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma.
    Hu M; Shi H; Xu Z; Liu W
    Tumour Biol; 2013 Jun; 34(3):1879-85. PubMed ID: 23645212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
    Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
    Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
    da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
    Wu D; Wu Y; Zhang X; Cong P; Lv X
    Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional +61G/A polymorphism in epidermal growth factor is associated with glioma risk among Asians.
    Xu X; Xi L; Zeng J; Yao Q
    PLoS One; 2012; 7(7):e41470. PubMed ID: 22829952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
    Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
    BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk.
    Guo J; Shi L; Li M; Xu J; Yan S; Zhang C; Sun G
    Tumour Biol; 2014 Jan; 35(1):573-9. PubMed ID: 23979976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
    Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
    Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between EGF +61 A/G polymorphism and increased risk of glioma.
    Liu X; Li L; Chen X; Wang X; Mu L; Li Y; Xu Q; Xie Q; Lu F
    Int J Biol Markers; 2009; 24(2):77-82. PubMed ID: 19634110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
    Li YL; Tian Z; Zhao L; Zhang CL
    Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the Thr241Met polymorphism of X-ray repair cross-complementing group 3 gene and glioma risk: evidence from a meta-analysis based on 4,136 cases and 5,233 controls.
    Lin J; Kou Y
    Tumour Biol; 2014 Jan; 35(1):425-32. PubMed ID: 23918307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphisms of epidermal growth factor 61 and susceptibility of lung cancer: A meta-analysis.
    Chen Q; Zheng Y; Wu B; Chen X; Ge P; Wang P
    Medicine (Baltimore); 2020 Apr; 99(17):e19456. PubMed ID: 32332599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between functional EGF+61 polymorphism and glioma risk.
    Costa BM; Ferreira P; Costa S; Canedo P; Oliveira P; Silva A; Pardal F; Suriano G; Machado JC; Lopes JM; Reis RM
    Clin Cancer Res; 2007 May; 13(9):2621-6. PubMed ID: 17473192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
    PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.